← FDA Drug Approvals (Drugs@FDA)

LEUKERAN

NDA · New Drug Application · Sponsor: WAYLIS THERAP · Approved 1957-03-18

Drug application

FDA Application #
NDA010669
Application type
New Drug Application
Brand name
LEUKERAN
Generic name
CHLORAMBUCIL
Active ingredients
CHLORAMBUCIL
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
WAYLIS THERAP
Manufacturer
Waylis Therapeutics LLC
First approval
1957-03-18

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown